CLDX
Celldex Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.59 / 10
Netural
Technical evaluation yields a 3.59/10 score, with the Bearish Engulfing pattern (8.33/10) offsetting the MACD Death Cross (1.43/10). The conflicting signals and scarce recent data imply a neutral, volatile trend that requires close monitoring for clearer direction.
Analysis Checks(1/3)
MACD Death Cross
Score1.43/10
Win Rate35.71%
Hist. Signals14
Avg Return0.08%
Score1.43/10
Win Rate35.71%
Hist. Signals14
Avg Return0.08%
MACD Golden Cross
Score1/10
Win Rate26.67%
Hist. Signals15
Avg Return-2.68%
Score1/10
Win Rate26.67%
Hist. Signals15
Avg Return-2.68%
Bearish Engulfing
Score8.33/10
Win Rate70.00%
Hist. Signals10
Avg Return5.24%
Score8.33/10
Win Rate70.00%
Hist. Signals10
Avg Return5.24%
MACD Death Cross
Score1.43/10
Win Rate35.71%
Hist. Signals14
Avg Return0.08%
Score1.43/10
Win Rate35.71%
Hist. Signals14
Avg Return0.08%
Bearish Engulfing
Score8.33/10
Win Rate70.00%
Hist. Signals10
Avg Return5.24%
Score8.33/10
Win Rate70.00%
Hist. Signals10
Avg Return5.24%
MACD Golden Cross
Score1/10
Win Rate26.67%
Hist. Signals15
Avg Return-2.68%
Score1/10
Win Rate26.67%
Hist. Signals15
Avg Return-2.68%
What is the current technical signals for CLDX?
- CLDX presents a Netural setup with a Technical Score of 3.59/10. Key technical indicators highlight an RSI of 41.00 and a MACD of -0.48, with the trend anchored by the 50-Day SMA at 26.41. Traders should monitor key support at 21.97 and resistance at 23.76.
